To the best of our knowledge, this is the first comprehensive in vitro and clinical study of PARP1 expression utilizing a well-defined in vitro model based on two kinds of normal primary melanocytes and four melanoma cell lines and a large cohort of cutaneous melanoma patients with long-term follow-up. The gene discussed is PARP1; the disease is melanoma.